EUDA Health Holdings (EUDA) Cash & Equivalents (2021 - 2025)

EUDA Health Holdings (EUDA) has 5 years of Cash & Equivalents data on file, last reported at $345145.0 in Q4 2025.

• On a quarterly basis, Cash & Equivalents rose 45.26% year-over-year to $345145.0 in Q4 2025; TTM through Dec 2025 was $345145.0, a 45.26% increase from a year earlier, with the FY2025 full-year figure at $345145.0, up 45.26% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $345145.0, up from $176584.0 in the prior quarter.
• Over the last five years, Cash & Equivalents for EUDA reached as high as $837292.0 in Q1 2023 and fell as low as $176584.0 in Q2 2025.
• Historically, Cash & Equivalents has averaged $372265.6 across 5 years, with a median of $293169.0 in 2022.
• Across the five-year window, Cash & Equivalents soared 312.9% in 2022 and plunged 75.91% in 2023, its largest moves.
• Year by year, Cash & Equivalents stood at $189996.0 in 2021, then surged by 312.9% to $784485.0 in 2022, then plunged by 75.91% to $189005.0 in 2023, then gained by 25.71% to $237605.0 in 2024, then soared by 45.26% to $345145.0 in 2025.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $345145.0 in Q4 2025, $176584.0 in Q2 2025, and $237605.0 in Q4 2024.